Zevra Therapeutics, Inc. (ZVRA)
8.66
+0.13
(+1.52%)
USD |
NASDAQ |
Dec 24, 12:59
8.64
-0.02
(-0.23%)
After-Hours: 13:59
Zevra Therapeutics SG&A Expense (TTM): 73.39M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 74.62M |
| XOMA Royalty Corp. | 32.68M |
| Akebia Therapeutics, Inc. | 112.54M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |